These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35680099)

  • 1. The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights.
    Halder S; Parte S; Kshirsagar P; Muniyan S; Nair HB; Batra SK; Seshacharyulu P
    Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188737. PubMed ID: 35680099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
    Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
    Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
    Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
    Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
    Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.
    Viswanadhapalli S; Luo Y; Sareddy GR; Santhamma B; Zhou M; Li M; Ma S; Sonavane R; Pratap UP; Altwegg KA; Li X; Chang A; Chávez-Riveros A; Dileep KV; Zhang KYJ; Pan X; Murali R; Bajda M; Raj GV; Brenner AJ; Manthati V; Rao MK; Tekmal RR; Nair HB; Nickisch KJ; Vadlamudi RK
    Mol Cancer Ther; 2019 Aug; 18(8):1341-1354. PubMed ID: 31142661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting LIF/LIFR signaling in cancer.
    Viswanadhapalli S; Dileep KV; Zhang KYJ; Nair HB; Vadlamudi RK
    Genes Dis; 2022 Jul; 9(4):973-980. PubMed ID: 35685476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.
    Zhang W; Shi X; Chen R; Zhu Y; Peng S; Chang Y; Nian X; Xiao G; Fang Z; Li Y; Cao Z; Zhao L; Liu G; Sun Y; Ren S
    Mol Ther; 2020 Nov; 28(11):2473-2487. PubMed ID: 32592689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of leukemia inhibitory factor (LIF), LIFR, gp130, and IL11 in the embryo implantation site of rat model with prenatal androgen-induced polycystic ovary syndrome.
    Javidan M; Changaei M; Ramezani Tehrani F; Mosaffa N; Noroozzadeh M; Hosseinzadeh R; Rajaei S
    Biochem Biophys Res Commun; 2022 May; 605():24-30. PubMed ID: 35306361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
    Dhingra K; Sahin A; Emami K; Hortobagyi GN; Estrov Z
    Breast Cancer Res Treat; 1998 Mar; 48(2):165-74. PubMed ID: 9596488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
    Fairlie WD; Uboldi AD; McCoubrie JE; Wang CC; Lee EF; Yao S; De Souza DP; Mifsud S; Metcalf D; Nicola NA; Norton RS; Baca M
    J Biol Chem; 2004 Jan; 279(3):2125-34. PubMed ID: 14585833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
    Song H; Lim H
    Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
    Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
    He SX; Song G; Shi JP; Guo YQ; Guo ZY
    Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor: a paracrine mediator of bone metabolism.
    Sims NA; Johnson RW
    Growth Factors; 2012 Apr; 30(2):76-87. PubMed ID: 22304408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer.
    Tang W; Ramasamy K; Pillai SMA; Santhamma B; Konda S; Pitta Venkata P; Blankenship L; Liu J; Liu Z; Altwegg KA; Ebrahimi B; Pratap UP; Li X; Valente PT; Kost E; Sareddy GR; Vadlamudi RK; Nair HB; Tekmal RR; Viswanadhapalli S
    Cell Death Discov; 2021 Aug; 7(1):216. PubMed ID: 34400617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of leukemia inhibitory factor receptor on the adipogenic differentiation of human bone marrow mesenchymal stem cells.
    Wang T; Yan R; Xu X; Yu H; Wu J; Yang Y; Li W
    Mol Med Rep; 2019 Jun; 19(6):4719-4726. PubMed ID: 31059010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
    J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive role of BDNF in therapy-induced neuroendocrine prostate cancer.
    Liu YN; Chen WY; Liu MK; Yeh HL; Chen WH; Jiang KC; Li HR; Chen ZQ; Wang WH; Abou-Kheir W; Wen YC
    Mol Oncol; 2024 Jun; 18(6):1665-1686. PubMed ID: 38381121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M
    Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
    Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.